Savara's Molbreevi BLA for autoimmune PAP was rejected by the FDA due to incomplete CMC data; the company plans to resubmit ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

Savara (SVRA) stock in focus as FDA issues a refusal to file letter regarding its marketing application for its lead drug, ...

By the latter half of this year, the company aims to submit a biologics license application to Korean authorities.

Vitalgen BioPharma Co., Ltd., a clinical-stage gene therapy company, today announced the completion of patient enrollment in March 2025 for its Phase III pivotal trial (VGR-R01-301) evaluating VGR-R01 ...

Candel Therapeutics essentially uses a dual-virus strategy with CAN-2409 and CAN-3110 immunotherapies. Find out why CADL ...

Pakistan ranked 7th globally for civilian casualties from explosive weapons in In 2024 | Every recorded suicide bombing in ...

Today, we left no doubt,” said BLA coach Nick Mone. “We showed up to play. We took some lumps [in the regular season] and it ...

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...

A suspected suicide bomber targeted a schoolbus in southwestern Pakistan killing at least four children and two adults on ...

Hundreds of mourners in Pakistan have attended the funerals of three schoolgirls and two soldiers killed in a suicide bombing ...